Today's Healthcare Pulse
FDA greenlights durvalumab combo for high‑risk bladder cancer
The FDA approved durvalumab (Imfinzi) combined with Bacillus Calmette‑Guerin for BCG‑naïve, high‑risk non‑muscle invasive bladder cancer. The POTOMAC trial enrolled 1,018 patients and showed a 32% reduction in disease recurrence risk (hazard ratio 0.68, p=0.015). Durvalumab is given at 1,500 mg IV every four weeks for up to 13 cycles.
Also developing:
By the numbers: Apogee Therapeutics raises $1.3B royalty financing
Residency Fill Rates Worsen for Primary Care: 20 Stats to Know
The Trilliant Health report shows primary‑care residency fill rates falling despite a surge in medical‑school applications and residency slots. In the 2026 match, family medicine was 16.4% unfilled, pediatrics 5.6% and internal medicine 4.6%, with the overall primary‑care fill rate 1.4% lower than 2025. Low reimbursement, average student debt exceeding $200,000, looming retirements and a static Medicare residency cap are driving the gap. The study urges targeted recruitment, rural training expansion and reimbursement reform to stem the decline.
ChatGPT for Clinicians: The Trap Sprung
OpenAI unveiled ChatGPT for Clinicians, a free GPT‑5.4‑powered assistant for verified U.S. physicians, nurse practitioners, physician assistants and pharmacists. The tool offers peer‑reviewed literature search, reusable workflow templates such as referral letters and prior authorizations, deep journal research, and built‑in...
The Specialty Facing a Million Dollar Gender Pay Gap
A Yale‑led study of the AAMC Faculty Salary Survey (2016‑2024) shows that female ophthalmologists in academia earn less than male peers at every rank. Women now represent a slight majority of assistant professors but only 30% of full professors and...
Edwards Raises 2026 Forecast as TAVR Sales Surge
Edwards Lifesciences raised its full‑year 2026 sales‑growth outlook to 9‑11% after reporting a 16.7% jump in first‑quarter revenue to $1.65 billion, driven by a 14.4% increase in TAVR sales to $1.2 billion. The company also lifted its TAVR growth forecast to 7‑9%...
Meal Sequence Study Shows Glucose Control Comparable to Drugs
Researchers published in Diabetes Care report that simply changing the order of foods—vegetables and protein first, carbs last—lowers post‑meal blood glucose peaks by more than 40% and reduces overall glucose exposure by 38.8%, effects comparable to some glucose‑lowering drugs. The...
Social Security Announces 2.8% COLA, Yet Retirees Still Feel Inflation Pinch
Social Security revealed a 2.8% cost‑of‑living adjustment for 2026, boosting monthly checks but leaving many retirees short after Medicare Part B premium hikes and a 20% erosion of purchasing power since 2010.
Postmarketing Requirements and Commitments: Reports
The FDA publishes annual reports in the Federal Register detailing the status of post‑marketing requirements (PMRs) and commitments (PMCs) for drugs and biologics, covering both CDER and CBER. These reports summarize data from internal databases and are updated quarterly on...
Trump's Executive Order Fast‑Tracks Psychedelic Therapy Review, Boosting Compass Pathways
President Donald Trump signed an executive order this weekend to shorten clinical‑trial and regulatory timelines for psychedelic medicines. The move shines a spotlight on Compass Pathways, whose late‑stage psilocybin candidate COMP360 is poised for an FDA filing and has $149.6 million...
TRT Gel/Injection Shows More Adverse Events Than Clomiphene
Interesting retrospective chart-based study in VA population - TRT gel/injection vs. clomiphene for hypogonadism. Matched populations at baseline. Far higher rates of AEs with gel/injection vs. clomiphene. "TRT was associated with an increased incidence of mortality, CVA, CAD, hypertension,...
Researchers Launch APOLLO, a 25‑Billion‑Event AI Model to Forecast Disease
Scientists at Mass General Brigham introduced APOLLO, a transformer‑based foundation model trained on 25.2 billion medical events from 7.2 million patients. The system outperformed existing tools on 322 clinical tasks, including a 0.92 AUROC for schizophrenia onset, signaling a new era for...
Michigan Senate Bills to Force Private Insurers to Cover Infertility Treatments
Michigan Senate Majority Leader Stephanie Chang introduced SB 922, mandating private health insurers to cover fertility diagnostics, IVF, egg preservation and embryo transfer. The bill, referred to the Senate Finance, Insurance and Consumer Protection Committee, could reshape coverage mandates and...
Glutamine Transport Boost Enhances CAR‑Macrophage Cancer Therapy in Mice
A Sun Yat‑sen University team engineered CAR‑macrophages to overexpress the glutamine transporter SLC38A2, dramatically improving phagocytosis and cytokine release against HER2‑positive breast cancer cells. In mouse models, the modified cells suppressed tumor growth far more than standard CAR‑macrophages, highlighting metabolic...
WHO Prequalifies First-Ever Malaria Treatment for Newborns and Infants, Adds New Diagnostic Tests
The World Health Organization has prequalified the first antimalarial drug formulated specifically for newborns and infants weighing 2‑5 kg—artemether‑lumefantrine—enabling public‑sector procurement for an estimated 30 million babies born each year in malaria‑endemic Africa. The agency also prequalified three rapid diagnostic tests that...
Secretary Kennedy’s Eight Major Health Policy Wins to Date
HHS Secretary Ryan Kennedy has highlighted eight major health policy achievements since his February confirmation, ranging from drug‑price reductions to new dietary guidelines. The Trump RX website now lets consumers purchase prescription drugs directly from manufacturers at lower costs, while the 2024...
Pressure Points: Aristeia on Its New Battlefield Tourniquet
Aristeia introduced its Generation 8 battlefield tourniquet, aimed at military, parapublic and civilian agencies. The new device features a slimmer polymer‑composite band, a single‑hand pull‑to‑apply mechanism and visual placement cues, delivering about a 30 % faster application than the previous model. Independent...
Creative Biolabs Unveils LNP Conjugation Platform to Accelerate Precision Gene Therapy
Creative Biolabs announced the commercial release of an enhanced lipid‑nanoparticle (LNP) conjugation platform that improves payload stability and tissue targeting for gene‑editing and RNA therapeutics. The platform integrates microfluidic manufacturing and programmable ligand attachment, promising faster preclinical timelines for biotech...
AAN 2026: Tavapadon Post-Hoc Analysis Strengthens Its D1/D5 Agonist Pitch
At the 2026 American Academy of Neurology meeting, AbbVie unveiled post‑hoc results from its Phase III TEMPO‑1 and TEMPO‑2 trials of tavapadon, a once‑daily oral D1/D5 partial agonist for early Parkinson’s disease. The analysis showed statistically significant improvements in seven of...
Photo of the Week: Airway Trauma Training
EMS1 staff, a team of seasoned writers, editors, and emergency medical professionals, deliver timely, actionable content for pre‑hospital care providers. The outlet emphasizes breaking news, expert advice, and practical tools to improve EMT and paramedic performance. It promotes free subscription...
Reprogrammed Cardiomyocytes Soften the Blow in Heart Attack
A recent study published in the Journal of Molecular and Cellular Cardiology demonstrates that partial reprogramming of mouse cardiomyocytes with three Yamanaka factors (OCT4, SOX2, KLF4 – OSK) enables the cells to complete cytokinesis after a heart attack. By dismantling...
Expert Tips for Treating and Preventing ITBS
PT/coach Duane Scotti is on the pod to chat about ITBS treatment & prevention. Watch: https://youtu.be/UKJEv4cIV1g
FDA Clears Single‑Trial Path for Cambium Bio’s Elate Ocular Gene Therapy
The U.S. Food and Drug Administration granted Cambium Bio a single‑trial approval route for its Elate Ocular gene therapy, allowing the CAMOMILE‑3 Phase 3 study to serve as the sole pivotal trial. The decision reduces clinical risk, accelerates market entry and...
5 Patterns Behind Health Care Startups that Fail
Health‑care startups often fail not because of weak technology but due to strategic missteps. Dr. Harsha Moole identifies five recurring patterns: solving conference‑level problems instead of bedside needs, building products without knowing the true buyer, mistaking FDA clearance for market...
AAN 2026: Head-to-Head Trial Shows Superiority of Qulipta for Migraine Prevention
AbbVie presented Phase IIIb TEMPLE trial data at AAN 2026, showing its oral gepant Qulipta outperforms topiramate in migraine prevention. Over 24 weeks, Qulipta had a 12.1% discontinuation rate versus 29.6% for topiramate and achieved a 73.7% responder rate (>50% reduction in...
JLL Launches Healthcare Facility Accreditation Program
JLL’s healthcare division unveiled the Accreditation Lifecycle Program (ALG), a multi‑year compliance solution designed to keep hospitals continuously ready for The Joint Commission’s new Accreditation 360 standards. The platform aligns with the Joint Commission’s cycle, centralizing drawings, inspections and audit trails...
Sanofi MS Drug Rejected in US Gets an Endorsement in Europe
Sanofi’s experimental multiple‑sclerosis drug tolebrutinib, marketed as Cenrifki, received a positive recommendation from the European Medicines Agency for secondary progressive MS, after the U.S. FDA rejected it earlier this year. The EMA’s endorsement paves the way for a final approval...
HIMSSCast: Medicaid as a Health IT Innovation Engine
Dr. Christopher R. Cogle argues that Medicaid, covering over 80 million Americans, functions as a powerful health‑IT innovation engine. Designing systems for the most complex, vulnerable populations has spurred advances in data infrastructure, managed‑care oversight, and population‑health analytics. The HIMSSCast episode...
AI May Be Approaching a New Phase in Healthcare, on Two Fronts
Physicians are adopting Anthropic's agentic AI tool Claude Code to build custom clinical applications, signaling a shift toward doctor‑led software development within health systems. The latest frontier model, Claude Mythos, can identify code vulnerabilities, prompting security leaders to warn of...
LogiPharma Europe: A New Model for Cold Chain Decision-Making
At LogiPharma Europe 2026, Roche’s global head of Distribution Technology, Raquel Vazquez, outlined a shift from experience‑based to data‑driven cold‑chain decision‑making. She highlighted the need to contextualize fragmented sensor data across lanes, products and environmental conditions to select the right packaging...
Official Statistics: Mefloquine (Larium) Prescribing in the UK Armed Forces: 12 September 2016 to 31 March 2026
The UK Ministry of Defence has published official statistics on mefloquine (Larium) prescribing within the armed forces from September 2016 through March 2026, following a policy shift introduced in 2016. The data reveal a steady decline in mefloquine use, increased...
Most Pediatric Flu Deaths Occur in Unvaccinated Kids
#Flu season is over, but pediatric flu deaths continue to be reported. In the week ending 4/18, 6 more deaths were reported to #CDC. They bring the season's total so far to 149 deaths in kids; more such reports may...
Novo Nordisk's Breakthrough Launch at Attractive 11x PE
Watch the launch of the holy grail of pharma. Beautiful And still at a PE of ~11x. $NVO
Health Plans Adopt Standardized Approach to Prior Authorization
Health plans, including UnitedHealthcare, Cigna, Aetna, Humana and major Blue Cross entities, announced a voluntary initiative to use a standardized electronic prior‑authorization (e‑PA) format beginning Jan. 1, 2027. The new standard will cover common services such as orthopedic surgery, CT scans and...
Lilly Slides as FDA Plans Psychedelic Voucher Program
Lilly tumbles on Foundayo’s shaky week; FDA to issue vouchers for psychedelics https://t.co/kWvYtFeif0 $LLY - 4% $NVO + 6% $REGN $AMGN $BBOT #biotech
Health System Failure: A Personal Apology
our health system is SO broken. So sorry you had to experience this so directly...
How Northwell Health Engages Specialists in Value-Based Care
Northwell Health, overseeing 29 hospitals and 800+ ambulatory sites, is tackling the specialist‑centric gap in value‑based care. While most ACO contracts focus on primary‑care metrics, specialists account for the bulk of utilization costs and patient complexity. To bridge this, Northwell...
Highly Credentialed Health Experts Made Completely Insane, Debunked Claims About COVID Vaccines
The blog argues that highly credentialed health experts repeatedly issued misleading statements about COVID‑19, from flip‑flopping on mask mandates to overstating vaccine ability to halt infection and transmission. It cites a study by a credentialed group that alleges these experts...
Gil Bashe’s Insights Reshape AI-Driven Healthcare
⚡️I've learned more from @Gil_Bashe than just about anyone I've ever met. His friendship and collaboration means the world to me. 📖His book Healing the Sick Care System is a must read. https://t.co/kFbNd6GKho #AI #medicine #heathcare https://t.co/hg9HEAaNZJ
New Psychedelic Trials Target Depression and PTSD
Compass Pathways’ psilocybin (COMP360) for treatment-resistant depression (TRD) Usona Institute’s psilocybin for major depressive disorder (MDD) Otsuka’s methylone (TSND-201) for PTSD
Rethinking Nutrition Policy on Ultra-Processed Food
A new review challenges the blanket vilification of ultra‑processed foods, showing that health risk varies by sub‑category rather than processing alone. Processed meats, sugary and artificially sweetened drinks, and certain fats consistently raise cardiometabolic risk, while whole‑grain breads, cereals, and...
J&J Lands CE Mark for Surgical Stapler that Works with Ottava Robot
Johnson & Johnson has secured a CE mark for its Ethicon 4000 surgical stapler, enabling European surgeons to use the device in open and laparoscopic procedures now. The stapler is engineered to work with J&J’s upcoming Ottava robotic platform, which has...
Genentech Partners With Comedy Icon Damon Wayans and diaTribe to Address Diabetes-Related Vision Loss With ‘All Eyes on DME’ Campaign
Genentech, part of the Roche Group, launched the "All Eyes on DME" campaign to raise awareness of diabetic macular edema (DME) using humor and personal stories. The initiative partners with comedian Damon Wayans, who lives with type 2 diabetes, and advocacy...
Drug Digest: Examining the Architecture of Next-Gen Biotherapeutic Modalities
Minaris Advanced Therapies’ chief commercial and technology officer, Dr. Eytan Abraham, discussed how multifunctional biotherapeutics are merging antibodies, ADCs and engineered cells to create more precise, personalized treatments. He highlighted multi‑targeting cell designs that improve specificity and reduce disease escape,...
Biogen Seeks Darzalex Rivalry in China for Multiple Myeloma with Felzartamab Deal
Biogen has secured exclusive rights to TJ Biopharma’s anti‑CD38 antibody felzartamab in Greater China for up to $850 million, including control of a pending biologics licence application for relapsed and refractory multiple myeloma. The drug will be manufactured domestically at TJ...
Voices: Brittney Jaskowiak, SVP, Client Success, Dragonfly Health
Dragonfly Health is positioning its integrated DME‑and‑pharmacy platform as a strategic solution for hospice providers facing mounting pressure to improve visibility, cut operational friction, and leverage utilization data. By unifying two of hospice’s largest cost centers under a single, technology‑driven...
Lantern Pharma to Debut Public Demonstration of withZeta.ai – A Platform to Conquer Rare Cancers on April 30 Following AACR...
Lantern Pharma announced a public, unscripted demonstration of its withZeta.ai AI co‑scientist platform on April 30, 2026. CEO Panna Sharma will lead two live sessions—morning and afternoon ET—to showcase real‑time drug‑discovery workflows for rare cancers. The event follows the platform’s...
Novartis Pulls Pluvicto Prostate Cancer Label Expansion Filing in the EU
Novartis has pulled its European Medicines Agency (EMA) application to extend the label of Pluvicto, its lutetium‑177 PSMA‑targeted radioligand therapy, into earlier‑stage prostate cancer. The drug already received approval for this indication in the United States and the United Kingdom,...
Disciplinary Inquiry Resumes Into Doctor’s Alleged Baby Blunder 16 Years Ago
The Hong Kong Medical Council resumed a disciplinary inquiry into Dr. Sit Sou‑chi for allegedly failing to promptly investigate newborn Li Yuanjian’s seizures in December 2009, a lapse that left the child with cerebral palsy and quadriplegia. After a public...
GPX4 Inhibitors Eradicate Senescent Tumor Cells, Boost Chemo Efficacy
GPX4 inhibitors discovered that kill "zombie" senescent cells from tumors (increased w/ chemoRx) and effective in multiple preclinical models vs cancer, a new potential strategy to pursue in clinical trials https://t.co/lYX7xkI9xF @NatureCellBio https://t.co/mxbjzRQPck
How AI Is Changing Healthcare Compliance and Why Most Apps Aren’t Ready
Artificial intelligence is now a staple in healthcare compliance, powering automated audit‑trail analysis, policy management, continuous risk scoring, and rapid incident detection. However, once AI models ingest protected health information, they fall under HIPAA, state privacy statutes, and breach‑notification rules,...
Flexibility Is Key to Future-Ready Hospital Design
Hospital leaders are moving away from permanently installing equipment toward modular, reconfigurable spaces that can evolve with emerging technologies. Cleveland Clinic CIO Sarah Hatchett emphasizes that flexibility enables rapid adoption of AI, digital health tools, and new treatment modalities. The...